Provided by Tiger Trade Technology Pte. Ltd.

Alnylam Pharmaceuticals

329.36
+13.274.20%
Volume:111.48K
Turnover:36.18M
Market Cap:43.51B
PE:141.36
High:329.59
Open:319.06
Low:319.03
Close:316.09
52wk High:495.55
52wk Low:205.87
Shares:132.11M
Float Shares:126.15M
Volume Ratio:1.04
T/O Rate:0.09%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.33
EPS(LYR):2.33
ROE:73.28%
ROA:6.81%
PB:55.14
PE(LYR):141.36

Loading ...

Sep 12, 2025

Major Issues Report

Form 8-K - Current report
Sep 10, 2025

Major Issues Report

Form 8-K - Current report
Sep 09, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 29, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 19, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 18, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 15, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 31, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 31, 2025

Major Issues Report

Form 8-K - Current report
Jun 18, 2025

Major Issues Report

Form 8-K - Current report
Jun 02, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 30, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 30, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 22, 2025

Correspondence

Form CORRESP - Correspondence
May 15, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 13, 2025

Major Issues Report

Form 8-K - Current report
May 01, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 01, 2025

Major Issues Report

Form 8-K - Current report
Mar 24, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 24, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities